Tzalwel schreef op 4 januari 2021 05:31:
€2 50 price target moet toch wel voor 5 procent stijging kunnen zorgen vandaag.
Oppenheimer Stick to Their Buy Rating for Pharming Group
Investing.com | Jan 01, 2021 04:02AM ET
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Pharming Group on Thursday, setting a price target of EUR2.5, which is approximately 99.82% above the present share price of 1.54.
Singh expects Pharming Group to post earnings per share (EPS) of 0.01 for the first quarter of 2021.
The current consensus among 0 TipRanks analysts is for a Hold rating of shares in Pharming Group, with an average price target of .
The analysts price targets range from a high of to a low of .